1AIO | CRYSTAL STRUCTURE OF A DOUBLE-STRANDED DNA CONTAINING THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Takahara, P.M., Rosenzweig, A.C., Frederick, C.A., Lippard, S.J. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.60 | ||||||||||||
ligand | BRU, CPT | enzyme |
| ||||||||||||
note | 1AIO supersedes 1GPG | ||||||||||||||
Primary reference | Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin., Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ, Nature 1995 Oct 19;377(6550):649-52. PMID:7566180 |
Data retrieval |
View 1AIO in 3D |
Visual 3D analysis of 1AIO |
Structure-derived information |
Sequence-derived information |
Other resources with information on 1AIO |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |